The AAPS 101st Annual Meeting

Evaluation Of The Relative Safety Of Oncoplastic Reduction Compared To Traditional Reduction
Elijah Bingham, BS, Shamit Prabhu, MD, Nirbhay S. Jain, MD, Andrew Da Lio, MD, Charles Tseng, MD, Christopher Crisera, MD, Jaco Festekjian, MD, Jason Roostaeian, MD, Ginger Slack, MD, Michael Delong, MD.

Division of Plastic Surgery, University of California Los Angeles, Los Angeles, California, USA

Introduction

Oncoplastic reduction (OnR) combines breast conservation therapy with reduction mammoplasty to provide effective tumor resection while achieving aesthetically pleasing surgical outcomes.
Oncoplastic reduction theoretically includes the aggregate risks of both lumpectomy and bilateral breast reduction (BBR) surgeries
Our goal was to understand if oncoplastic reduction confers a higher operative risk profile than bilateral breast reduction alone

The AAPS 101st Annual Meeting

Evaluation Of The Relative Safety Of Oncoplastic Reduction Compared To Traditional Reduction

Poster Presenter

Authors

Affiliations

Part of Topic